DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
DaVita Inc. (NYSE: DVA) has announced its participation in the upcoming Barclays Global Healthcare Conference 2025. The company's CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat with investors on March 11, 2025, at 9:00 a.m. EDT.
DaVita is a comprehensive kidney care provider with a 25-year track record in clinical quality and innovation. As of December 31, 2024, the company serves 281,100 patients across 3,166 outpatient dialysis centers, with 2,657 centers in the United States and 509 centers across 13 other countries. The company specializes in various aspects of kidney health, from disease progression management to transplantation support and home dialysis services.
DaVita Inc. (NYSE: DVA) ha annunciato la sua partecipazione alla prossima Barclays Global Healthcare Conference 2025. Il CFO dell'azienda, Joel Ackerman, e il VP del Gruppo delle Relazioni con gli Investitori, Nic Eliason, parteciperanno a una chiacchierata informale con gli investitori il 11 marzo 2025, alle 9:00 EDT.
DaVita è un fornitore completo di cure renali con un'esperienza di 25 anni nella qualità clinica e nell'innovazione. Al 31 dicembre 2024, l'azienda assiste 281.100 pazienti in 3.166 centri di dialisi ambulatoriale, di cui 2.657 centri negli Stati Uniti e 509 centri in 13 altri paesi. L'azienda si specializza in vari aspetti della salute renale, dalla gestione della progressione della malattia al supporto per il trapianto e ai servizi di dialisi a domicilio.
DaVita Inc. (NYSE: DVA) ha anunciado su participación en la próxima Barclays Global Healthcare Conference 2025. El CFO de la compañía, Joel Ackerman, y el VP del Grupo de Relaciones con Inversores, Nic Eliason, participarán en una charla informal con los inversores el 11 de marzo de 2025, a las 9:00 a.m. EDT.
DaVita es un proveedor integral de atención renal con 25 años de experiencia en calidad clínica e innovación. A partir del 31 de diciembre de 2024, la empresa atiende a 281,100 pacientes en 3,166 centros de diálisis ambulatoria, con 2,657 centros en los Estados Unidos y 509 centros en 13 otros países. La compañía se especializa en varios aspectos de la salud renal, desde la gestión de la progresión de la enfermedad hasta el apoyo a trasplantes y servicios de diálisis en casa.
다비타 Inc. (NYSE: DVA)는 다가오는 바클레이스 글로벌 헬스케어 컨퍼런스 2025에 참여한다고 발표했습니다. 회사의 CFO인 Joel Ackerman과 투자자 관계 그룹 부사장 Nic Eliason은 2025년 3월 11일 오전 9:00 EDT에 투자자들과의 대화에 참여할 예정입니다.
다비타는 25년의 임상 품질 및 혁신 경험을 가진 종합 신장 관리 제공업체입니다. 2024년 12월 31일 기준으로, 이 회사는 281,100명의 환자를 3,166개의 외래 투석 센터에서 치료하고 있으며, 이 중 2,657개 센터는 미국에, 509개 센터는 13개국에 있습니다. 이 회사는 질병 진행 관리, 이식 지원 및 자가 투석 서비스 등 신장 건강의 다양한 측면을 전문으로 합니다.
DaVita Inc. (NYSE: DVA) a annoncé sa participation à la prochaine Barclays Global Healthcare Conference 2025. Le CFO de la société, Joel Ackerman, et le VP du Groupe des Relations Investisseurs, Nic Eliason, participeront à une discussion informelle avec les investisseurs le 11 mars 2025 à 9h00 EDT.
DaVita est un fournisseur complet de soins rénaux avec 25 ans d'expérience en qualité clinique et innovation. Au 31 décembre 2024, l'entreprise s'occupe de 281 100 patients dans 3 166 centres de dialyse ambulatoire, dont 2 657 centres aux États-Unis et 509 centres dans 13 autres pays. L'entreprise se spécialise dans divers aspects de la santé rénale, de la gestion de la progression de la maladie au soutien à la transplantation et aux services de dialyse à domicile.
DaVita Inc. (NYSE: DVA) hat seine Teilnahme an der bevorstehenden Barclays Global Healthcare Conference 2025 angekündigt. Der CFO des Unternehmens, Joel Ackerman, und der Gruppen-VP für Investor Relations, Nic Eliason, werden am 11. März 2025 um 9:00 Uhr EDT in einem informellen Gespräch mit Investoren teilnehmen.
DaVita ist ein umfassender Anbieter von Nierenpflege mit einer 25-jährigen Erfolgsbilanz in klinischer Qualität und Innovation. Zum 31. Dezember 2024 betreut das Unternehmen 281.100 Patienten in 3.166 ambulanten Dialysezentren, davon 2.657 Zentren in den Vereinigten Staaten und 509 Zentren in 13 weiteren Ländern. Das Unternehmen spezialisiert sich auf verschiedene Aspekte der Nierengesundheit, von der Krankheitsverlaufskontrolle bis hin zu Transplantationsunterstützung und häuslichen Dialyse-Diensten.
- None.
- None.
To view the live webcast, visit the Barclays page and create a free registration.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2024, DaVita served approximately 281,100 patients at 3,166 outpatient dialysis centers, of which 2,657 centers were located in the United States and 509 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-barclays-global-healthcare-conference-2025-302394668.html
SOURCE DaVita
FAQ
When and where will DaVita (DVA) present at the Barclays Healthcare Conference 2025?
How many dialysis centers does DaVita (DVA) operate globally as of 2024?
What is DaVita's (DVA) current patient count worldwide?
Which DaVita (DVA) executives will participate in the Barclays conference?
What services does DaVita (DVA) provide in kidney care?
